Approval · Notice of Compliance 8853 · 2007
PROPOFOL INJECTION: Notice of Compliance 8853
Issued June 21, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8853
- Date
- June 21, 2007
- Company
- Hospira Healthcare CorporationKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Anesthetic / sedative
- Canadian reference product
- DIPRIVAN
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROPOFOL INJECTION | 02242973 | Cancelled Post Market |
Medicinal ingredients
- PROPOFOL 10 MG per ML